# A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE

> **NCT00914966** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 20 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **BIOLOGICAL:** C1 inhibitor (human) [C1 INH]

## Key facts

- **NCT ID:** NCT00914966
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-31
- **Primary completion:** 2012-05-24
- **Final completion:** 2012-05-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914966, "A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00914966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*